Abstract

Previous studies, including our own, have reported that spermatozoa isolated from the testis have remarkably higher occurrence of aneuploidy once isolated from azoospermic men. This notion, however, did not translate into a lower pregnancy rate nor a greater proportion of miscarriages. Indeed, ICSI offspring generated from surgically retrieved gametes did not suffer from increased karyotypic aneuploidy than children generated from ejaculated specimens. In recent years, aneuploidy assessments on a larger number of cells and utilizing more chromosome probes have reported a progressive decrease in chromosomal aberrations in spermatozoa directly retrieved from the seminiferous tubules. In light of the availability of more accurate molecular genetic techniques, we have decided to challenge the notion that sampling epididymal and testicular tissues yields spermatozoa with higher incidence of aneuploidy than those retrieved in the ejaculate. In a retrospective manner, we have carried out an analysis by FISH with 9 chromosome probes on at least 1000 cells from the ejaculates of 87 consenting men and the specimens of 6 azoospermic men, while spermatozoa of fertile donors were used as control. Aneuploidy by FISH yielded 0.9% for the donor control but rose in the study group to 3.6% in the ejaculated, 1.2% for the epididymal, and 1.1% for testicular spermatozoa. There were no differences in autosomal or gonosomal disomies, nor nullisomies. In this group, once the specimens of these men were used for ICSI, ejaculated spermatozoa yielded a 22% clinical pregnancy rate that resulted in 62.5% pregnancy loss. The surgically retrieved specimens yielded a 50% clinical pregnancy rate that progressed to term. To confirm our findings, in a prospective analysis, DNA sequencing was carried out on the ejaculates and surgical samples of 22 men with various spermatogenic characteristics. In this comparison, the findings were similar with actually a higher incidence of aneuploidy in the ejaculated spermatozoa (n = 16) compared to those surgically retrieved (n = 6) (P<0.0001). For this group, the clinical pregnancy rate for the ejaculated specimens was 47.2% with 29.4% pregnancy loss, while the surgically retrieved yielded a 50% clinical pregnancy rate, all progressing to term. A subsequent prospective combined assessment on ejaculated and surgically retrieved spermatozoa by FISH and NGS was performed on non-azoospermic men with high DNA fragmentation in their ejaculate. The assessment by FISH evidenced 2.8% chromosomal defects in the ejaculated and 1.2% in testicular biopsies while by NGS became 8.4% and 1.3% (P = 0.02), respectively. Interestingly, we evidenced a pregnancy rate of 0% with ejaculated while 100% with the testicular spermatozoa in this latter group. This indicates that improved techniques for assessing sperm aneuploidy on a wider number of cells disproves earlier reports and corroborates the safe utilization of testicular spermatozoa with a positive impact on chances of pregnancy.

Highlights

  • Intracytoplasmic sperm injection (ICSI) is widely considered as the most effective treatment for male factor infertility, and it enables even azoospermic men to father their own child [1]

  • The multiple incidences of disomy, nullisomy, and diploidy were evaluated in at least 1000 spermatozoa. This assessment revealed an overall aneuploidy of 3.6% in men who provided ejaculated specimens (n = 87), 1.2% in the men who provided epididymal specimens (n = 2), and 1.1% in the men who provided testicular specimens (n = 4), compared to 0.9% in the donor specimens serving as a control

  • We found that for each chromosome assessed by fluorescence in situ hybridization (FISH), the incidence of aneuploidy appeared minute when compared to Copy Number Variations (CNVs) occurrences identified using NGS

Read more

Summary

Introduction

Intracytoplasmic sperm injection (ICSI) is widely considered as the most effective treatment for male factor infertility, and it enables even azoospermic men to father their own child [1]. It is important to have a proper anamnestic and physical evaluation of the male partner by the reproductive physician or urologist [2]. This assessment begins with a semen analysis, and once the patient is considered oligospermic or azoospermic, it is often supplemented by a peripheral karyotype or the detection of micro DNA deletions of the Y chromosome. A karyotype assessment of the spermatozoon with abnormal results assumes relevance in cases with adequate sperm parameters and, most significantly, in male partners of couples with a reproductive history characterized by recurrent pregnancy loss with an aneuploid conceptus, in spite of the absence of advanced maternal age. Targeted genetic screening is appropriate for azoospermic men known to have a higher incidence of constitutional karyotypic abnormality (Nakamura, el at., 2001) and where a higher incidence of aneuploidy in spermatozoa retrieved from their testis may be more prone, due to the impaired spermatogenesis [5]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call